Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
Total
Senior Subordinated Secured Convertible Notes
Common Stock
Common Stock
Class A and Class B Common Stock
Common Stock
Class A and Class B Common Stock
Senior Subordinated Secured Convertible Notes
Preferred Stock
Convertible Preferred Stock
Additional Paid-in Amount
Additional Paid-in Amount
Senior Subordinated Secured Convertible Notes
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2021     109,587,000 0   120,903,000          
Beginning balance (in shares) at Jan. 31, 2021                 (14,131,000)    
Beginning balance at Jan. 31, 2021 $ 193,853,000   $ 4,000 $ 0   $ 424,992,000 $ 122,061,000   $ (23,831,000) $ 787,000 $ (330,160,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon initial public offering, net of underwriting discounts and issuance costs (in shares)       18,288,000              
Issuance of common stock upon initial public offering, net of underwriting discounts and issuance costs 275,954,000           275,954,000        
Conversion of convertible preferred stock and senior subordinated secured convertible notes (in shares)       120,903,000 9,694,000 (120,903,000)          
Conversion of convertible preferred stock and senior subordinated secured convertible notes 0 $ 82,114,000   $ 4,000   $ (424,992,000) 424,988,000 $ 82,114,000      
Stock-based compensation - equity classified awards 25,265,000           25,265,000        
Reclassification of common stock to class A and class B common stock (in shares)     (117,176,000) 117,176,000              
Reclassification of common stock to class A and class B common stock 0   $ (4,000) $ 4,000              
Exercise of stock options (in shares)     7,589,000 968,000              
Exercise of stock options 16,659,000           16,659,000        
Net exercise of common stock warrants (in shares)       230,000              
Issuance of common stock under deferred stock compensation plan (in shares)       1,770,000              
Other comprehensive income (loss) (797,000)                 (797,000)  
Net loss (46,842,000)                   (46,842,000)
Ending balance (in shares) at Jul. 31, 2021     0 269,029,000   0          
Ending balance (in shares) at Jul. 31, 2021                 (14,131,000)    
Ending balance at Jul. 31, 2021 546,206,000   $ 0 $ 8,000   $ 0 947,041,000   $ (23,831,000) (10,000) (377,002,000)
Beginning balance (in shares) at Apr. 30, 2021     115,279,000 0   120,903,000          
Beginning balance (in shares) at Apr. 30, 2021                 (14,131,000)    
Beginning balance at Apr. 30, 2021 195,625,000   $ 4,000 $ 0   $ 424,992,000 138,724,000   $ (23,831,000) 387,000 (344,651,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issuance of common stock upon initial public offering, net of underwriting discounts and issuance costs (in shares)       18,288,000              
Issuance of common stock upon initial public offering, net of underwriting discounts and issuance costs 275,954,000           275,954,000        
Conversion of convertible preferred stock and senior subordinated secured convertible notes (in shares)       120,903,000 9,694,000 (120,903,000)          
Conversion of convertible preferred stock and senior subordinated secured convertible notes 0 $ 82,114,000   $ 4,000   $ (424,992,000) 424,988,000 $ 82,114,000      
Stock-based compensation - equity classified awards 16,609,000           16,609,000        
Reclassification of common stock to class A and class B common stock (in shares)     (117,176,000) 117,176,000              
Reclassification of common stock to class A and class B common stock 0   $ (4,000) $ 4,000              
Exercise of stock options (in shares)     1,897,000 968,000              
Exercise of stock options 8,652,000           8,652,000        
Net exercise of common stock warrants (in shares)       230,000              
Issuance of common stock under deferred stock compensation plan (in shares)       1,770,000              
Other comprehensive income (loss) (397,000)                 (397,000)  
Net loss (32,351,000)                   (32,351,000)
Ending balance (in shares) at Jul. 31, 2021     0 269,029,000   0          
Ending balance (in shares) at Jul. 31, 2021                 (14,131,000)    
Ending balance at Jul. 31, 2021 $ 546,206,000   $ 0 $ 8,000   $ 0 947,041,000   $ (23,831,000) (10,000) (377,002,000)
Beginning balance (in shares) at Jan. 31, 2022       256,481,000              
Beginning balance (in shares) at Jan. 31, 2022 (14,130,784)               (14,131,000)    
Beginning balance at Jan. 31, 2022 $ 515,849,000     $ 8,000     982,122,000   $ (23,831,000) (820,000) (441,630,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Conversion of convertible preferred stock and senior subordinated secured convertible notes (in shares)       717,000              
Conversion of convertible preferred stock and senior subordinated secured convertible notes 6,213,000     $ 1,000     6,212,000        
Stock-based compensation - equity classified awards 29,086,000           29,086,000        
Exercise of stock options and vesting of RSUs (in shares)       2,515,000              
Exercise of stock options and vesting of RSUs $ 10,429,000           10,429,000        
Exercise of stock options (in shares) 2,309,000                    
Other comprehensive income (loss) $ (4,347,000)                 (4,347,000)  
Net loss $ (49,215,000)                   (49,215,000)
Ending balance (in shares) at Jul. 31, 2022       259,713,000              
Ending balance (in shares) at Jul. 31, 2022 (14,130,784)               (14,131,000)    
Ending balance at Jul. 31, 2022 $ 508,015,000     $ 9,000     1,027,849,000   $ (23,831,000) (5,167,000) (490,845,000)
Beginning balance (in shares) at Apr. 30, 2022       257,945,000              
Beginning balance (in shares) at Apr. 30, 2022                 (14,131,000)    
Beginning balance at Apr. 30, 2022 506,358,000     $ 8,000     1,001,102,000   $ (23,831,000) (4,003,000) (466,918,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Conversion of convertible preferred stock and senior subordinated secured convertible notes (in shares)       717,000              
Conversion of convertible preferred stock and senior subordinated secured convertible notes 6,213,000     $ 1,000     6,212,000        
Stock-based compensation - equity classified awards 16,624,000           16,624,000        
Exercise of stock options and vesting of RSUs (in shares)       1,051,000              
Exercise of stock options and vesting of RSUs 3,911,000           3,911,000        
Other comprehensive income (loss) (1,164,000)                 (1,164,000)  
Net loss $ (23,927,000)                   (23,927,000)
Ending balance (in shares) at Jul. 31, 2022       259,713,000              
Ending balance (in shares) at Jul. 31, 2022 (14,130,784)               (14,131,000)    
Ending balance at Jul. 31, 2022 $ 508,015,000     $ 9,000     $ 1,027,849,000   $ (23,831,000) $ (5,167,000) $ (490,845,000)